The Oncology Institute, Inc. TOI Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s investing cash flow?
- The Oncology Institute, Inc. (TOI) reported investing cash flow of -$1.04M in Q1 2026.
- How has The Oncology Institute, Inc.'s investing cash flow changed year-over-year?
- The Oncology Institute, Inc.'s investing cash flow decreased by 415.8% year-over-year, from -$202K to -$1.04M.
- What is the long-term trend for The Oncology Institute, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s investing cash flow has grown at a -29.1% compound annual growth rate (CAGR), from -$12.15M to -$3.07M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.